Objectives

After participating in this educational activity, attendees should be able to:
1| Review the key evidence that informed the development of SMFM guidelines for the diagnosis and management of fetal growth restriction.
2| Discuss areas of controversy and limitations within current guidelines, including Doppler use, growth standards, and clinical thresholds.
3| Apply evidence-based principles alongside clinical judgment to common real-world scenarios in fetal growth restriction.

Presenter(s): 
Juliana Gevaerd Martins, MD
Associate Professor of Maternal Fetal Medicine

*Session will not be recorded*

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Juliana Gevaerd Martins, MDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
05/21/2026 - 8:00am to 9:00am EDT
Location: 
Lundy Board Room & Zoom
759 Chestnut St
Wesson, Ground Floor
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.